Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

BACKGROUND: Dermatomyositis and polymyositis (DM/PM) are rare, incurable inflammatory diseases that cause progressive muscle weakness and can be associated with increased medical resource use (MRU). When corticosteroid treatment is unsuccessful, patients may receive intravenous immunoglobulin (IVIg)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clinicoecon Outcomes Res
Egile Nagusiak: Knight, Tyler, Bond, T Christopher, Popelar, Breanna, Wang, Li, Niewoehner, John W, Anastassopoulos, Kathryn, Philbin, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2017
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5440004/
https://ncbi.nlm.nih.gov/pubmed/28553129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S130992
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak